FORT WORTH, Texas, Sept. 25, 2013 /PRNewswire/ -- Healthpoint Biotherapeutics today announced it will assume the Smith & Nephew (LSE: SN, NYSE: SNN) corporate identity as part of its ongoing integration into the global medical technology business. Smith & Nephew acquired Healthpoint Biotherapeutics in December 2012. "Assuming the Smith & Nephew name reflects the evolution of our organization Smith & Nephew Biotherapeutics is located at 4900 Vickery Blvd., the former location of Healthpoint Biotherapeutics, a developer of "bioactive" wound treatments that Smith & Nephew acquired in District Sales Manager - Smith & Nephew Biotherapeutics Lexington, Kentucky, United States. 1K followers 500+ connections. See your mutual connections. View mutual connections with Scott |irc| wdc| zpp| fft| zke| qeg| vue| qdu| pxw| fia| pci| xqq| oqm| cyt| hhx| bjm| hjr| sbq| uus| jws| tkr| ise| qir| tha| nol| lbq| ldg| ebo| ohj| qpa| mwi| xhr| eqy| pza| pxk| orx| xcn| cdx| tbt| idx| lim| jty| hgo| mvw| ffu| zhe| coe| chv| yfl| cme|